DOvEE - Diagnosing Ovarian & Endometrial Cancer Early

Official Title

Diagnosing Ovarian & Endometrial Cancer Early (DOvEE) by Targeting Symptomatic Women

Summary:

This study hopes to improve early detection of ovarian cancer. It will determine if women with bloating, abdominal distension, abdominal/pelvic pain, increased urinary frequency and/or early satiety, benefit from earlier surgery after screening by CA-125 ovarian cancer biomarker and transvaginal ultrasound.

Trial Description

Primary Outcome:

• Proportion of diagnoses in early, curable stage.

• Number of participants with physical morbidity related to the program as a measure of safety and tolerability

View this trial on ClinicalTrials.gov